Cannabix
Technologies to Deliver Breath Logix Alcohol Screening Device to
Australia
Cannabix is
developing alcohol and marijuana breathalyzer devices to give law
enforcement and employers a tool to enhance public safety
Vancouver, British Columbia, Canada
-- April 30, 2024 -- InvestorsHub NewsWire -- Cannabix Technologies
Inc. (CSE:
BLO) (OTC
PINK: BLOZF) (Frankfurt: 8CT) (the "Company or Cannabix")
developer of alcohol and marijuana breathalyzer screening devices
for law enforcement and the workplace reports that it has commenced
discussions with Breathalyser Sales & Service Pty Ltd. of
Sydney, Australia ("Breathalyser SSP") for the sales distribution
of the Company's Breath Logix Alcohol screening device (see Figure
1). Breathalyser SSP is a leading distributor of alcohol and drug
testing devices for employers and personal use, offering well
established alcohol product lines like Draeger
and AlcoMeasure
for the Australian market with
regional offices in Perth, Melbourne and Brisbane. Breathalyser SSP
has clients in a range of sectors including mining, oil and gas,
industrial, trucking, warehousing and technology. Cannabix will be
shipping its Breath Logix Industrial
Series device to Breathalyser SSP for
evaluation, preliminary marketing and business development
purposes.
Ben Smit, Managing Director of
Breathalyser Sales & Service Pty Ltd., stated, "We have been
impressed with the Cannabix team's ability to develop the Breath
Logix wall mounted device over the last several months.
Breathalyser Sales and Service is Australia's oldest distributor
and leader in the supply, service & calibration of drug and
alcohol testing equipment. We see the Breath Logix
Industrial
Series fitting into the Australian
marketplace well due to is rugged exterior, ease of use and unique
cartridge technology. Autonomous employee alcohol screening
is a major segment of our business and we welcome innovative
products like the Breath Logix device."
Figure 1.
Breath Logix Industrial Series
device
Breath Logix
Industrial
Series Features
The Breath Logix
Industrial
Series is a weather resistant device
with a host of requested features including patent pending
pre-calibrated cartridge technology which will allow site safety
administrators to easily maintain their devices, and eliminate the
need for costly calibration equipment and time-consuming site
visits from technicians for maintenance.
This device can be used for
pre-access alcohol testing, random testing, start-of-shift testing,
pre-employment testing, return-to-work testing and post-incident
testing. The device is currently being piloted
as a solution for the 24/7 sobriety program which exists in several
states.
The Breath Logix Alcohol device
automatically checks the sobriety of a user and can take a picture
to confirm and record identity while a breath sample is being
delivered. Upon detection of positive breath alcohol result, the
device will deliver a precise Blood Alcohol Content (BAC) level on
the screen, and send a real-time alert via text message, e-mail and
to a dedicated web portal. Furthermore, the system logs user BAC
for incident reporting and historical
investigations. The Breath Logix helps organizations
save money by deploying an autonomous alcohol screening device
which eliminates the need for dedicated alcohol screening
administrators using conventional handheld devices.
There is no assurance that evaluators
of the Company's breathalyzer technology will come to terms on
distribution or enter into a sales agreement with the
Company.
About Cannabix Technologies
Inc.
Cannabix Technologies Inc. is a
developer of marijuana and alcohol breathalyzer technologies for
law enforcement, workplaces and laboratories. Cannabix is
developing delta-9 THC and alcohol screening devices. Delta-9 THC
is the psychoactive component of marijuana that causes impairment.
Breath testing for delta-9 THC would allow employers and law
enforcement to identify recent marijuana use.
Cannabix is the developer of Breath Logix Series of autonomous
breath alcohol detection devices for employers and a range of other
settings.
We seek Safe
Harbor.
On behalf of
the Board of Directors
"Rav Mlait"
CEO
Cannabix Technologies Inc.
For further information, contact the
Company at
info@cannabixtechnologies.com
The CSE has not
reviewed and does not accept responsibility for the adequacy or
accuracy of this release.
Cautionary Statement Regarding
Forward-Looking Statements
This press release contains
forward-looking information that involves various risks and
uncertainties regarding future events. Such forward-looking
information can include without limitation statements based on
current expectations involving a number of risks and uncertainties
and are not guarantees of future performance of the Company, such
as final development of a commercial or prototype product(s),
successful trial or pilot of company technologies, no assurance
that commercial sales of any kind actually materialize; no
assurance the Company will have sufficient funds to complete
product development. There are numerous risks and uncertainties
that could cause actual results and the Company's plans and
objectives to differ materially from those expressed in the
forward-looking information, including: (i) adverse market
conditions; (ii) risks regarding protection of proprietary
technology; (iii) the ability of the Company to complete
financings; (iv) the ability of the Company to develop and market
its future product; and (v) risks regarding government regulation,
managing and maintaining growth, the effect of adverse publicity,
litigation, competition and other factors which may be identified
from time to time in the Company's public announcements and
filings. There is no assurance that its development of breathalyzer
technology will provide any benefit to the Company, and no
assurance that any proposed new products will be built, will be
successful in beta testing or clinical trials. There is no
assurance that evaluators of the Company's breathalyzer technology
will agree or come to terms on distribution or enter into a sales
agreement, of any kind. There is no assurance that existing "patent
pending" technologies licensed by the Company will receive patent
status by regulatory authorities. The Company is not currently selling
commercial breathalyzers. Actual results and future events could
differ materially from those anticipated in such information. These
and all subsequent written and oral forward-looking information are
based on estimates and opinions of management on the dates they are
made and are expressly qualified in their entirety by this notice.
Except as required by law, the Company does not intend to update
these forward-looking statements.
501-3292 Production Way, Burnaby,
B.C., V5A 4R4
Phone: (604)
551-7831 Fax: 604-676-2767
info@cannabixtechnologies.com
cannabixtechnologies.com
